The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.

Q4 2024 Earnings Conference Call February 14, 2025 3:00 AM ETCompany ParticipantsMasamichi Terabatake - Group President ...

Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease MACHINE LEARNING MODEL USING ...

Japan Tobacco on Thursday reported a 9.7% increase in annual adjusted operating profit from its tobacco business, thanks to ...

Venice is readying for the 19th International Architecture Exhibition of La Biennale di Venezia, which will take place May 10 ...

Use your imagination and place yourself on a busy Tokyo street. Pachinko machines go plinkety-plink and multicolored electric signs strobe and scroll. The seething crush of pedestrians moves like a ...